shopping cart Your cart is empty
  • Home
  • Market Research
  • Photopheresis Products Market By Type (Closed System, Open System), By Therapeutic Area (Cutaneous T-Cell Lymphoma, Solid Organ Tr...

Photopheresis Products Market By Type (Closed System, Open System), By Therapeutic Area (Cutaneous T-Cell Lymphoma, Solid Organ Transplant Rejections, Autoimmune Diseases, Graft Versus Host Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Published By: Brisk Insights | Published On: May 28, 2021

 

Therapeutic apheresis has been present in healthcare system for several years dating back to the 1950s. currently, apheresis and its modalities are acknowledged as effective first-line treatment or adjunctive treatment for a wide range of disorders. Some common therapeutic apheresis modalities include plasmapheresis, leukapheresis, blood cell apheresis, lipidpheresis, plateletpheresis and photopheresis. Photopheresis, also known as extracorporeal phototherapy, is gaining new popularity in the market, particularly due to its growing demand in off-label applications, greater efficacy in treating graft versus host disease and prevention of organ transplant rejection.

 

Graft Versus Host Disease to Lead the Market in Terms of Revenue

 

Over half of the cost incurred in transplantation is consumed by post-transplant care costs, mainly including immunosuppressive therapies. As a majority of transplant patients develop episodes of chronic rejection, insurance companies are keen to consider management therapies such as photopheresis for patients that do not respond to conventional immunosuppressive therapies. Additionally, more than half patients receiving allogeneic bone marrow transplant that develop graft versus host disease. Photopheresis is reported to respond positively in majority of the graft versus host conditions and cases of organ transplant rejection. Therefore, growing evidence in support of efficacy of photopheresis, more recommendations from physicians and surgeons will occur, therefore augment the market growth for photopheresis products.

 

Sustained Demand for Closed Systems to Support the Photopheresis Products Market Growth

 

The first system for photopheresis approved by the FDA was the UVAR by Therakos, a closed system (1988). Since then, several open and closed systems have been approved worldwide for clinical use. Open photopheresis systems use separate compartments for cell separation and photoactivation. As different steps are involved in therapy administration, there is therefore a high risk of contamination or patient re-infusion error. Thus, open are only used in certified centers for separate handling of blood components. However, closed systems do not face this limitation and therefore are widely used ensuring their sustained demand and dominance in the global market.

 

Widespread Presence of Apheresis Centers Ensuring the Supremacy of North America

 

Currently, North America dominates the global photopheresis market. Early introduction of apheresis and its further modalities, and widespread presence of advanced apheresis and blood processing centers are the prime factors driving the prominent position of North America on the global front. Greater affordability in the patient population, facilitated by the favorable reimbursement scenario further contributes to the dominance of North America. However, striation in the region has resulted in diversion in focus of manufacturers to the emerging markets of Asia Pacific and Latin America. Asia Pacific market is mainly characterized by widening outreach of healthcare infrastructure, increasing disposable incomes in patient population, growing awareness and rapid approvals to advanced treatments. The global photopheresis products market is fragmented in nature yet highly competitive. The players are mainly identified by their product differentiation. Some prime companies engaged in this space are Terumo Corporation, Malinckrodt Pharmaceuticals, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, and others.

 

Historical & Forecast Period

 

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

 

This study offers an analysis of every mentioned segment for the period from 2016 to 2026 while considering 2017 as the base year for further forecasting. Moreover, compounded annual growth rates (CAGRs) for every segment are covered and calculated for the period from 2018 to 2026.

 

Report Scope by Segments

 

This report on photopheresis products offers quantitative assessment in terms of current and future market size, along with qualitative analysis considering the market dynamics and competitive environment. For this purpose, the market is segmented by product types, therapeutic area, and geographical distribution.

 

By Type (2016–2026; US$ Mn)

 

  • Closed System
  • Open System

 

By Therapeutic Area (2016–2026; US$ Mn)

 

  • Cutaneous T-cell Lymphoma
  • Solid Organ Transplant Rejections
  • Autoimmune Diseases
  • Graft Versus Host Diseases

 

Geography Segment (2016–2026; US$ Mn)

 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of Middle East and Africa

 

The market trends prevalent in the global Photopheresis Products Market are scrutinized while considering the current and future roadmap of the market. Assessment of market dynamics such as drivers, restraints, and opportunities offer comprehensions about the pros and cons of the market. This report also assesses the positions of the major market players and offers their brief profiles based on the business overview, product portfolio respective to the market, financial information and key developments. The players profiled in this report include Asahi Spectra USA, Inc., Avantes BV, Cogentix Medical, Inc. (LABORIE Medical Technologies), Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Ocean Optics, Inc., Olympus Medical Systems (Olympus Corporation), SOPRO-COMEG GmbH, Smith & Nephew Plc, Stryker Corporation, and Excelitas Technologies Corp. 

 

Key questions answered in this report

 

  • How is the current status of the Photopheresis Products Market in 2017?
  • How will the market progress through the forecast period?
  • What are the major drivers and challenges prevalent in the global photopheresis products market?
  • Which product type currently governs the market and what will be its status over the forecast period?
  • Which therapeutic area is expected to witness the fastest growth during the forecast period?
  • What is the current status of Asia Pacific market in the global photopheresis products market?
  • Will the market position of North America be challenged by Asia Pacific within the forecast period?
  • What is the current competitive scenario in the global market?
  • Which are the major strategies employed by the market players for strengthening their market position?

 

Chapter 1 Preface


1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Approach Adopted
1.3.4 Top-Down Approach
1.3.5 Bottom-Up Approach
1.3.6 Phase III – Expert Panel Review
1.3.7 Assumptions
1.4 Market Segmentation

 

Chapter 2 Executive Summary


2.1 Market Snapshot: Global Photopheresis Products Market
2.1.1 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
2.1.2 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
2.1.3 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)

 

Chapter 3 Photopheresis Products: Market Dynamics and Outlook


3.1 Introduction
3.2 Market Drivers
3.2.1 XXXX XXXX XXXX XXXX XXXX
3.2.1 Driver 2
3.3 Challenges
3.3.1 Challenge 1
3.3.2 Challenge 2
3.4 Opportunities
3.4.1 Opportunity 1
3.5 Attractive Investment Proposition, by Geography, 2017
3.6 Competitive Landscape, by Key Players, 2017

 

Chapter 4 Global Photopheresis Products Market, by Type


4.1 Overview
4.2 Closed System
4.3 Open System

 

Chapter 5 Global Photopheresis Products Market, by Therapeutic Area


5.1 Overview
5.2 Cutaneous T-cell Lymphoma
5.3 Solid Organ Transplant Rejections
5.4 Autoimmune Diseases
5.5 Graft Versus Host Diseases

 

Chapter 6 Global Photopheresis Products Market, by Geography


6.1 Overview
6.2 North America
6.2.1 North America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2 North America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
6.2.3 North America Photopheresis Products Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1 U.S.
6.2.3.1.1 U.S. Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.2.3.1.2 U.S. Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.2.3.2 Canada
6.2.3.2.1 Canada Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.2.3.2.2 Canada Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3 Europe
6.3.1 Europe Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2 Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
6.3.3 Europe Photopheresis Products Market, by Country/Region (US$ Mn)
6.3.3.1 U.K.
6.3.3.1.1 U.K. Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.1.2 U.K. Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3.3.2 Germany
6.3.3.2.1 Germany Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.2.2 Germany Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3.3.3 Rest of Europe
6.3.3.3.1 Rest of Europe Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.3.2 Rest of Europe Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4 Asia Pacific
6.4.1 Asia Pacific Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.2 Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3 Asia Pacific Photopheresis Products Market, by Country/Region, 2016-2026 (US$ Mn)
6.4.3.1 Japan
6.4.3.1.1 Japan Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.1.2 Japan Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3.2 China
6.4.3.2.1 China Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.2.2 China Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3.3 Rest of Asia Pacific
6.4.3.3.1 Rest of Asia Pacific Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.3.2 Rest of Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5 Latin America
6.5.1 Latin America Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.2 Latin America Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3 Latin America Photopheresis Products Market, by Country/Region, 2016-2026 (US$ Mn)
6.5.3.1 Brazil
6.5.3.1.1 Brazil Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.1.2 Brazil Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3.2 Mexico
6.5.3.2.1 Mexico Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.2.2 Mexico Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3.3 Rest of Latin America
6.5.3.3.1 Rest of Latin America Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.3.2 Rest of Latin America Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6 Middle East & Africa
6.6.1 Middle East & Africa Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.2 Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6.3 Middle East & Africa Photopheresis Products Market, by Region, 2016-2026 (US$ Mn)
6.6.3.1 GCC
6.6.3.1.1 GCC Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.3.1.2 GCC Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6.3.2 Rest of Middle East & Africa
6.6.3.2.1 Rest of Middle East & Africa Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.3.2.2 Rest of Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)

 

Chapter 7 Company Profiles


7.1 Haemonetics Corporation
7.2 Fresenius Kabi AG
7.3 Macopharma
7.4 Mallinckrodt Pharmaceuticals
7.5 Med Tech Solutions GmbH
7.6 Terumo Corporation

TABLE 1 Market Snapshot: Global Photopheresis Products Market Volume
TABLE 2 Market Snapshot: Global Photopheresis Products Market Value
TABLE 3 Global Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 5 Global Photopheresis Products Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 8 North America Photopheresis Products Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 U.S. Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 U.S. Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 11 Canada Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Canada Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 15 Europe Photopheresis Products Market, by Country/Region 2016 – 2026 (US$ Mn)
TABLE 16 U.K. Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 17 U.K. Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 18 Germany Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Germany Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 20 Rest of Europe Photopheresis Products Market Value, by Type, 2016 – 2026 (US$ Mn)
TABLE 21 Rest of Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 22 Asia Pacific Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 23 Asia Pacific Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 24 Asia Pacific Photopheresis Products Market, by Country/Region 2016 – 2026 (US$ Mn)
TABLE 25 Japan Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 26 Japan Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 27 China Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 28 China Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 29 Rest of Asia Pacific Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 30 Rest of Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 31 Latin America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 32 Latin America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 33 Brazil Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 34 Brazil Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 35 Mexico Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 36 Mexico Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 37 Rest of Latin America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 38 Rest of Latin America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 39 Middle East & Africa Photopheresis Products Market Value, by Type, 2016 – 2026 (US$ Mn)
TABLE 40 Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 41 GCC Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 42 GCC Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 43 Rest of Middle East & Africa Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 44 Rest of Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 45 Haemonetics Corporation: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 46 Fresenius Kabi AG: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 47 Macopharma: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 48 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 49 Med Tech Solutions GmbH: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 50 Terumo Corporation: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)

FIG. 1 Global Photopheresis Products Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Photopheresis Products Market Segmentation
FIG. 4 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
FIG. 5 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
FIG. 6 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Photopheresis Products Manufacturers, 2017
FIG. 9 Global Closed System Photopheresis Products Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Open System Photopheresis Products Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Photopheresis Products Market for Cutaneous T-Cell Lymphoma, 2016 – 2026 (US$ Mn)
FIG. 12 Global Photopheresis Products Market for Solid Organ Transplant Rejections, 2016 – 2026 (US$ Mn)
FIG. 13 Global Photopheresis Products Market for Autoimmune Diseases, 2016 – 2026 (US$ Mn)
FIG. 14 Global Photopheresis Products Market for Graft Versus Host Diseases, 2016 – 2026 (US$ Mn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)